Pharmaceutical Contract Services Market

1 / 16
About This Presentation
Title:

Pharmaceutical Contract Services Market

Description:

Offer pharmaceutical companies a range of services covering all phases of drug development ... ingredients, intermediates and services to drug companies ... – PowerPoint PPT presentation

Number of Views:66
Avg rating:3.0/5.0
Slides: 17
Provided by: tammy71

less

Transcript and Presenter's Notes

Title: Pharmaceutical Contract Services Market


1
Pharmaceutical Contract Services Market
2
A. Contract research organizations
  • Offer pharmaceutical companies a range of
    services covering all phases of drug development
  • Increasing emphasis on informatics services to
    complement other activities
  • Enable big pharma firms to staff for valleys
    rather than peaks of research cycle
  • Facilitate worldwide testing of new products
  • Dependence on pharmaceutical companies budgets
    creates high volatility in results
  • CROs involvement in genetic research will have a
    long-term payback

3
Company Profiles
  • Quintiles Transnational Corp. largest CRO, with
    revenues of 2.15 bil. Provides integrated
    product and commercial development services to
    the pharma, biotech and medical industries
  • Covance Offers broad range of outsourced
    development services growth through
    acquisitions diversifying into biotechnology
  • Parexel International Corp. Clinical research,
    consulting, medical marketing and informatics,
    growth through acquisitions
  • continued next page

4
Company Profiles (contd)
  • Pharmaceutical Product Development, Inc.
    includes PPD Discovery (genomics technology), PPD
    Development (analytical lab and Phase I-IV
    clinical development services, and PPD Virtual
    (consulting)
  • Inveresk Research Group pre-clinical and
    pharmacology evaluation services acquired Clin
    Trials Research
  • Kendle International clinical research and
    drug development services acquisitive
  • ICON plc clinical research for pharma and
    biotech industries

5
  • Contract Research Organizations (CROs) Summary
  • ( in millions)

¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
6
B. Manufacturing services organizations
  • U.S. market for outsourced pharmaceutical
    manufacturing is growing
  • Integration of pharmaceutical research,
    manufacturing and packaging services
  • Chemical Industry still has less outsourcing than
    other industries

7
  • Benefits of outsourcing can be measured by
    comparing new paradigm with former pharmaceutical
    business model

New Paradigm
Old Paradigm
Entire Supply Chain
Focus
Factories
Discount Cash Flow (DCF)
COGS
Costs
Recycle Capacity
Add Capacity
New Products
Outsource
Add Capacity
Existing Products
Under-utilized Assets
Avoid Capital Investment Reinvest cash in RD and
in Marketing
Results
Source Patheon Co. website
8
Company Profiles
  • Lonza Group AG supplier of active chemical
    ingredients, intermediates and biotechnology
    solutions to the pharma and agrochemical
    industries 1.3 billion in revenues
  • CCL Industries Canadian co. providing
    outsourcing in personal care, OTC pharma and oral
    care products
  • Cambrex Corp. Life sciences company providing
    pharmaceutical ingredients, intermediates and
    services to drug companies
  • Patheon Co. Vertically integrated approach to
    pharmaceutical development with manufacturing
    expertise in both prescription and OTC products
  • continued next page..

9
Company Profiles (contd)
  • Catalytica acquired by DSM in Dec. 2000.
    Pharmaceutical and fine chemical contract
    manufacturer
  • ChiRex aqcquired by Rhodia in Sept. 2000.
    Contract research and contract manufacturing of
    active pharmaceutical ingredients
  • Draxis Pharma unit of Draxis Health inc.
    Contract manufacturer with ability to produce a
    variety of dosage forms also packaging
    capability
  • DPT Laboratories acquired West Pharmaceutical
    Services contract manufacturing unit in November
    2001.

10
  • Manufacturing Services Companies Summary
  • ( in millions)

¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
11
C. Information Technology Companies
  • Sector Fundamentals
  • Provide the following services
  • lt Health portals (health information sites)
  • lt Connectivity and communications services
  • lt E-commerce, including on-line health insurance
    and drug prescriptions
  • Rising costs compel industry participants to
    examine use of technology
  • Consumers are becoming more active in their
    health care management, as managed care is
    redefining the doctor-patient relationship

12
C. Information Technology Companies (contd)
  • Health care had under-invested in information
    technology relative to other industries
  • As the health care delivery model changes,
    participants need additional information to
    measure outcomes

13
Company Profiles
  • IMS Health Inc. Split off from Cognizant in
    Jan. 1998. Provides market information and
    decision support services to the healthcare
    sector
  • Web MD Corp. Leverages Internet to provide
    services that connect participants in health care
    sector and automate workflow
  • Cerner Corp. Information management systems,
    primarily sold to hospitals
  • IDX Systems Corp. Information systems and
    medical transcription services
  • continued next page ..

14
Company Profiles (contd)
  • NDC Health Corp. Point-of-service systems, high
    volume, network-based information solutions and
    information management systems
  • Eclipsys Corp. Healthcare information systems
  • The TriZetto Group Internet hosting and
    software consulting services
  • Allscripts Inc. Point-of-care medication
    management, distribution and software

15
  • Information Technology Companies Summary
  • ( in millions)

¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
16
D. Developing Trends
  • Pharmaceutical and consumer product manufacturers
    expected to increase their contract activities to
    reduce costs and improve speed to market
  • Complexity of FDA approval process enhances
    values of already approved proprietary
    methodologies and heightens attractiveness of
    contract services
  • European manufacturers of pharmaceutical and fine
    chemicals such as DSM and Lonza may be contract
    service providers to establish a presence in the
    US market
  • Competitive environment in outsourcing has
    intensified, due to existing production
    overcapacities at the pharma companies coupled
    with the declining number of approvals for new
    products
  • Future consolidation likely through mergers and
    acquisitions
Write a Comment
User Comments (0)